User:Crusher123/Kalos Therapeutics

Kalos Therapeutics is a biomedical company with the exclusive patent to develop the ANP (atrial natriuretic peptide) family of peptides as a new mechanism for the treatment of cancer. [1]

Kalos has been covered by ABC News [2] on Good Morning America, and profiled in Business Week. [3] The company aggressively targets diseases caused by an abnormally high growth rate of cells (hyper proliferation), [4] and is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.[5]

References

edit

External Links